Cocrystal Pharma, Inc. — Proxy Solicitation & Information Statement 2026

May 27, 2026

DEFA14A 1 formdefa14-a.htm DEFA14A html

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary
Proxy Statement |
| --- | --- |
| ☐ | Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive
Proxy Statement |
| ☒ | Definitive
Additional Materials |
| ☐ | Soliciting
Material under §240.14a-12 |

Cocrystal Pharma, Inc.

Field: Rule-Page

Field: /Rule-Page

(Name of Registrant as Specified In Its Charter)

Field: Rule-Page

Field: /Rule-Page

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

| ☒ | No
fee required. |
| --- | --- |
| ☐ | Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |

| (1) | Title
of each class of securities to which transaction applies: |
| --- | --- |
| (2) | Aggregate
number of securities to which transaction applies: |
| (3) | Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined): |
| (4) | Proposed
maximum aggregate value of transaction: |
| (5) | Total
fee paid: |

| ☐ | Fee
paid previously with preliminary materials. |
| --- | --- |
| ☐ | Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |

| (1) | Amount
Previously Paid: |
| --- | --- |
| (2) | Form,
Schedule or Registration Statement No.: |
| (3) | Filing
Party: |
| (4) | Date
Filed: |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CONTROL ID:

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE COCRYSTAL PHARMA, INC. 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JULY 14, 2026

| DATE:
July 14, 2026 |
| --- |
| TIME:
AT 11:00 AM ET |
| LOCATION: To be held virtually by calling 877-407-3088 (toll free). |

THIS COMMUNICATION IS NOT A FORM OF VOTING AND ONLY REPRESENTS A NOTICE TO ACCESS A MORE COMPLETE SET OF PROXY MATERIALS (INCLUDING THE PROXY STATEMENT AND FORM 10-K ) AVAILABLE TO YOU ON THE INTERNET. WE ENCOURAGE YOU TO ACCESS AND REVIEW ALL OF THE IMPORTANT INFORMATION CONTAINED IN THE PROXY MATERIALS BEFORE VOTING. THE PROXY MATERIALS ARE AVAILABLE AT www.COCP.vote To submit your proxy while visiting this site, you will need the control ID in THIS NOTICE.

| ● | IF YOU DECIDE TO VIEW THE PROXY MATERIALS
AND VOTE YOUR SHARES ONLINE, |
| --- | --- |
| | Step 1: Go to www.COCP.vote |
| | Step 2: To view or download the proxy materials,
click on the link that describes the material you wish to view or download. For example, to view or download the Proxy Statement, click
on the “Proxy Statement” link. |
| | Step 3: To vote online, click on the designated
link and follow the on-screen instructions. YOU MAY VOTE ONLINE UNTIL 11:59 PM EASTERN TIME ON July 13, 2026. |
| ● | IF YOU WANT TO RECEIVE A PAPER COPY OF THE
PROXY MATERIALS INCLUDING THE PROXY CARD, YOU MUST REQUEST ONE. THERE IS NO CHARGE TO YOU FOR REQUESTING A COPY. TO FACILITATE TIMELY
DELIVERY PLEASE MAKE THE REQUEST, AS INSTRUCTED BELOW, BEFORE JUNE 30, 2026. |

HOW TO REQUEST PAPER COPIES OF OUR MATERIALS

●	●	●	●
PHONE:	FAX:	INTERNET:	EMAIL:
CALL
TOLL FREE	SEND
THIS CARD TO	www.COCP.vote	proxy@equitystock.com
1-212-575-5757	347-584-3644	FOLLOW
THE ON-SCREEN INSTRUCTIONS.	INCLUDE
YOUR CONTROL ID
IN YOUR EMAIL.

Field: Page; Sequence: 2

Field: /Page

Voting items

The board of directors of COCRYSTAL PHARMA, INC. (the “company”) recommends that you vote “for” FOR EACH OF THE NOMINEES IN PROPOSAL 1, “FOR” ON PROPOSALS 2, 3, and 4

1. Elect five directors for a one-year term expiring at the next annual meeting of stockholders.

2. Ratify the selection of Weinberg & Company as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

3. Approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting.

Note: To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.

THE BOARD OF DIRECTORS HAS FIXED THE CLOSE OF BUSINESS ON MAY 19, 2026, AS THE RECORD DATE FOR THE DETERMINATION OF MEMBERS ENTITLED TO RECEIVE NOTICE OF THE ANNUAL MEETING AND TO VOTE THE COMPANY’S COMMON SHARES THEY HELD ON THAT DATE AT THE MEETING OR ANY POSTPONEMENT OR ADJOURNMENT OF THE MEETING.

PLEASE NOTE–THIS IS NOT A PROXY CARD - YOU CANNOT VOTE BY RETURNING THIS CARD. TO VOTE YOUR SHARES, YOU MUST VOTE ONLINE OR REQUEST A PAPER COPY OF PROXY MATERIALS TO RECEIVE A PROXY CARD.

IF YOU WISH TO ATTEND AND VOTE AT THE MEETING, PLEASE FOLLOW INSTRUCTIONS LISTED ON THE REVERSE SIDE.

YOUR VOTE IS IMPORTANT!

Field: Page; Sequence: 3; Options: Last

Field: /Page